Tilray Brands, Inc.
Viés de alta

$TLRY numbs pain of bear stock market

Tilray CEO Brendan Kennedy proclaims "medical cannabis is disrupting Big Pharma."
novartistilrayTrend Analysis

Também em:

Aviso legal